These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 26584530)
1. Recombinant vaccinia virus GLV-1h68 is a promising oncolytic vector in the treatment of cholangiocarcinoma. Pugalenthi A; Mojica K; Ady JW; Johnsen C; Love D; Chen NG; Aguilar RJ; Szalay AA; Fong Y Cancer Gene Ther; 2015 Dec; 22(12):591-6. PubMed ID: 26584530 [TBL] [Abstract][Full Text] [Related]
2. Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68. Ehrig K; Kilinc MO; Chen NG; Stritzker J; Buckel L; Zhang Q; Szalay AA J Transl Med; 2013 Mar; 11():79. PubMed ID: 23531320 [TBL] [Abstract][Full Text] [Related]
3. Vaccinia virus GLV-1h237 carrying a Walker A motif mutation of mouse Cdc6 protein enhances human breast tumor therapy in mouse xenografts. Hofmann E; Grummt F; Szalay AA Int J Oncol; 2011 Mar; 38(3):871-8. PubMed ID: 21249314 [TBL] [Abstract][Full Text] [Related]
4. Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68. Yu YA; Galanis C; Woo Y; Chen N; Zhang Q; Fong Y; Szalay AA Mol Cancer Ther; 2009 Jan; 8(1):141-51. PubMed ID: 19139123 [TBL] [Abstract][Full Text] [Related]
5. Effective oncolytic vaccinia therapy for human sarcomas. He S; Li P; Chen CH; Bakst RL; Chernichenko N; Yu YA; Chen N; Szalay AA; Yu Z; Fong Y; Wong RJ J Surg Res; 2012 Jun; 175(2):e53-60. PubMed ID: 22341347 [TBL] [Abstract][Full Text] [Related]
6. Efficient colonization and therapy of human hepatocellular carcinoma (HCC) using the oncolytic vaccinia virus strain GLV-1h68. Gentschev I; Müller M; Adelfinger M; Weibel S; Grummt F; Zimmermann M; Bitzer M; Heisig M; Zhang Q; Yu YA; Chen NG; Stritzker J; Lauer UM; Szalay AA PLoS One; 2011; 6(7):e22069. PubMed ID: 21779374 [TBL] [Abstract][Full Text] [Related]
7. Regression of human prostate tumors and metastases in nude mice following treatment with the recombinant oncolytic vaccinia virus GLV-1h68. Gentschev I; Donat U; Hofmann E; Weibel S; Adelfinger M; Raab V; Heisig M; Chen N; Yu YA; Stritzker J; Szalay AA J Biomed Biotechnol; 2010; 2010():489759. PubMed ID: 20379368 [TBL] [Abstract][Full Text] [Related]
8. Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice. Chen NG; Yu YA; Zhang Q; Szalay AA J Transl Med; 2011 Sep; 9():164. PubMed ID: 21951588 [TBL] [Abstract][Full Text] [Related]
9. Combination treatment with oncolytic Vaccinia virus and cyclophosphamide results in synergistic antitumor effects in human lung adenocarcinoma bearing mice. Hofmann E; Weibel S; Szalay AA J Transl Med; 2014 Jul; 12():197. PubMed ID: 25030093 [TBL] [Abstract][Full Text] [Related]
10. Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus. Zhang Q; Yu YA; Wang E; Chen N; Danner RL; Munson PJ; Marincola FM; Szalay AA Cancer Res; 2007 Oct; 67(20):10038-46. PubMed ID: 17942938 [TBL] [Abstract][Full Text] [Related]
11. Novel oncolytic agent GLV-1h68 is effective against malignant pleural mesothelioma. Kelly KJ; Woo Y; Brader P; Yu Z; Riedl C; Lin SF; Chen N; Yu YA; Rusch VW; Szalay AA; Fong Y Hum Gene Ther; 2008 Aug; 19(8):774-82. PubMed ID: 18754710 [TBL] [Abstract][Full Text] [Related]
12. Use of GLV-1h68 for Vaccinia Virotherapy and Monitoring. Frentzen A; Geissinger U; Tsoneva D; Stritzker J Methods Mol Biol; 2015; 1317():225-37. PubMed ID: 26072410 [TBL] [Abstract][Full Text] [Related]
13. Gene therapy using therapeutic and diagnostic recombinant oncolytic vaccinia virus GLV-1h153 for management of colorectal peritoneal carcinomatosis. Eveno C; Mojica K; Ady JW; Thorek DL; Longo V; Belin LJ; Gholami S; Johnsen C; Zanzonico P; Chen N; Yu T; Szalay AA; Fong Y Surgery; 2015 Feb; 157(2):331-7. PubMed ID: 25616946 [TBL] [Abstract][Full Text] [Related]
14. Virotherapy of canine tumors with oncolytic vaccinia virus GLV-1h109 expressing an anti-VEGF single-chain antibody. Patil SS; Gentschev I; Adelfinger M; Donat U; Hess M; Weibel S; Nolte I; Frentzen A; Szalay AA PLoS One; 2012; 7(10):e47472. PubMed ID: 23091626 [TBL] [Abstract][Full Text] [Related]
15. A novel genetically modified oncolytic vaccinia virus in experimental models is effective against a wide range of human cancers. Haddad D; Chen N; Zhang Q; Chen CH; Yu YA; Gonzalez L; Aguilar J; Li P; Wong J; Szalay AA; Fong Y Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S665-74. PubMed ID: 22258815 [TBL] [Abstract][Full Text] [Related]
18. Oncolytic vaccinia virus GLV-1h68 strain shows enhanced replication in human breast cancer stem-like cells in comparison to breast cancer cells. Wang H; Chen NG; Minev BR; Szalay AA J Transl Med; 2012 Aug; 10():167. PubMed ID: 22901246 [TBL] [Abstract][Full Text] [Related]
19. A novel vaccinia virus with dual oncolytic and anti-angiogenic therapeutic effects against triple-negative breast cancer. Gholami S; Marano A; Chen NG; Aguilar RJ; Frentzen A; Chen CH; Lou E; Fujisawa S; Eveno C; Belin L; Zanzonico P; Szalay A; Fong Y Breast Cancer Res Treat; 2014 Dec; 148(3):489-99. PubMed ID: 25391896 [TBL] [Abstract][Full Text] [Related]
20. Combination of fractionated irradiation with anti-VEGF expressing vaccinia virus therapy enhances tumor control by simultaneous radiosensitization of tumor associated endothelium. Buckel L; Advani SJ; Frentzen A; Zhang Q; Yu YA; Chen NG; Ehrig K; Stritzker J; Mundt AJ; Szalay AA Int J Cancer; 2013 Dec; 133(12):2989-99. PubMed ID: 23729266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]